EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+6.72%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$1.31B
AUM Growth
+$1.31B
(-2.3%)
Cap. Flow
-$14M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
61.23%
Holding
86
New
16
Increased
25
Reduced
27
Closed
12
Top Buys
| 1 |
Insmed
INSM
|
$77.4M |
| 2 |
Repligen
RGEN
|
$23.5M |
| 3 |
Inspire Medical Systems
INSP
|
$15M |
| 4 |
Novo Nordisk
NVO
|
$12.1M |
| 5 |
HCA Healthcare
HCA
|
$10.2M |
Top Sells
| 1 |
Natera
NTRA
|
$65.5M |
| 2 |
Pfizer
PFE
|
$30.6M |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$26.2M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$21.2M |
| 5 |
Tenet Healthcare
THC
|
$18.5M |
Sector Composition
| 1 | Healthcare | 99.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Merus
MRUS
$4.98B
| $3.93M | 0.27% | 66,474 -53,008 | -44% | -$3.14M |
|
52
MoonLake Immunotherapeutics
MLTX
$3.54B
| $3.15M | 0.22% | +71,596 | New | +$3.15M |
|
|
AMRN
53
Amarin Corp
AMRN
$311M
| $2.96M | 0.2% | 4,308,527 -1,904,221 | -31% | -$1.31M |
|
54
Guardant Health
GH
$8.41B
| $2.87M | 0.2% | 99,377 -350,209 | -78% | -$10.1M |
|
55
InflaRx
IFRX
$108M
| $2.73M | 0.19% | 1,566,930 +261,790 | +20% | +$456K |
|
56
Avantor
AVTR
$9.18B
| $2.66M | 0.18% | 125,394 | – | – |
|
57
Tourmaline Bio
TRML
$601M
| $2.63M | 0.18% | +204,781 | New | +$2.63M |
|
58
IQVIA
IQV
$32.4B
| $2.57M | 0.18% | 12,178 | – | – |
|
59
Alector
ALEC
$238M
| $2.46M | 0.17% | 541,739 +5,568 | +1% | +$25.3K |
|
60
Immunovant
IMVT
$2.56B
| $2.45M | 0.17% | 92,909 -162,617 | -64% | -$4.29M |
|
61
Xoma
XOMA
$392M
| $2.18M | 0.15% | 91,907 -5,158 | -5% | -$122K |
|
|
AUTL
62
Autolus Therapeutics
AUTL
$399M
| $2.13M | 0.15% | +610,902 | New | +$2.13M |
|
63
Terns Pharmaceuticals
TERN
$609M
| $1.95M | 0.13% | 286,266 +3,232 | +1% | +$22K |
|
|
MREO
64
Mereo BioPharma
MREO
$272M
| $1.79M | 0.12% | +496,171 | New | +$1.79M |
|
65
Kura Oncology
KURA
$686M
| $1.49M | 0.1% | +72,317 | New | +$1.49M |
|
66
Absci
ABSI
$357M
| $1M | 0.07% | +325,509 | New | +$1M |
|
67
Fulcrum Therapeutics
FULC
$351M
| $948K | 0.06% | +152,965 | New | +$948K |
|
|
AFMD
68
DELISTED
Affimed
AFMD
| $907K | 0.06% | 166,460 | – | – |
|
69
Stoke Therapeutics
STOK
$1.08B
| $828K | 0.06% | 61,277 -228,723 | -79% | -$3.09M |
|
|
GTHX
70
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $456K | 0.03% | +199,963 | New | +$456K |
|
71
AC Immune
ACIU
$205M
| $396K | 0.03% | 99,313 -25,276 | -20% | -$101K |
|
72
Seres Therapeutics
MCRB
$166M
| $303K | 0.02% | 418,208 -970,736 | -70% | -$703K |
|
|
JBIO
73
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| – | – | -54,150 | Closed | -$1.6M |
|
74
Corbus Pharmaceuticals
CRBP
$115M
| – | – | -88,934 | Closed | -$3.49M |
|
75
CureVac
CVAC
$1.21B
| – | – | -515,691 | Closed | -$1.56M |
|